1 week Ago By ABMN Staff
Norges Bank bought a new stake in Avanos Medical, Inc. ( NYSE:AVNS – Free Report ) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 104,502 shares of the company’s stock, valued at approximately $1,664,000.
Norges Bank owned about 0.23% of Avanos Medical at the end of the most recent quarter. A number of other hedge funds have also recently made changes to their positions in the company.
FMR LLC raised its holdings in Avanos Medical by 34.6% in the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock valued at $3,216,000 after buying an additional 34,421 shares during the last quarter.
Barclays PLC raised its stake in shares of Avanos Medical by 446.2% during the third quarter. Barclays PLC now owns 96,194 shares of the company’s stock valued at $2,311,000 after acquiring an additional 78,583 shares during the last quarter.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Avanos Medical by 12.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company’s stock worth $2,607,000 after purchasing an additional 11,613 shares during the period.
JPMorgan Chase & Co. grew its stake in shares of Avanos Medical by 6.9% in the third quarter.
JPMorgan Chase & Co. now owns 69,571 shares of the company’s stock worth $1,672,000 after purchasing an additional 4,472 shares during the last quarter. Finally, Jane Street Group LLC increased its holdings in Avanos Medical by 35.
8% in the third quarter. Jane Street Group LLC now owns 65,650 shares of the company’s stock valued at $1,578,000 after purchasing an additional 17,306 shares during the period. 95.
17% of the stock is owned by institutional investors and hedge funds. Analyst Ratings Changes Separately, StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, March 19th.
Avanos Medical Stock Up 0.3 % Avanos Medical stock opened at $12.47 on Friday.
The firm has a market cap of $573.61 million, a price-to-earnings ratio of 36.67 and a beta of 1.
15. Avanos Medical, Inc. has a 52-week low of $12.
09 and a 52-week high of $25.36. The company has a debt-to-equity ratio of 0.
12, a quick ratio of 1.46 and a current ratio of 2.22.
The firm has a 50 day moving average price of $14.86 and a two-hundred day moving average price of $17.50.
Avanos Medical ( NYSE:AVNS – Get Free Report ) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.
40 by $0.03. Avanos Medical had a net margin of 2.
30% and a return on equity of 4.70%. The business had revenue of $179.
60 million for the quarter, compared to analysts’ expectations of $177.23 million. Equities analysts predict that Avanos Medical, Inc.
will post 1.32 EPS for the current year. Insider Buying and Selling In related news, SVP Kerr Holbrook sold 7,000 shares of the stock in a transaction on Thursday, March 6th.
The shares were sold at an average price of $15.25, for a total transaction of $106,750.00.
Following the transaction, the senior vice president now directly owns 82,047 shares of the company’s stock, valued at $1,251,216.75. This represents a 7.
86 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website . 2.
64% of the stock is currently owned by insiders. About Avanos Medical ( Free Report ) Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. ( NYSE:AVNS – Free Report ).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter ..
